We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of a Clinical Pharmacist Service on Health-related Quality of Life

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01016301
First Posted: November 19, 2009
Last Update Posted: November 18, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Susanna Wallerstedt, Sahlgrenska University Hospital, Sweden
  Purpose
The aim of the present study is to evaluate effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs.

Condition Intervention
Quality of Life Other: Pharmacist service

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Effects of a Clinical Pharmacist Service on Health-related Quality of Life

Further study details as provided by Susanna Wallerstedt, Sahlgrenska University Hospital, Sweden:

Primary Outcome Measures:
  • Health-related quality of life [ Time Frame: 6 months ]

Secondary Outcome Measures:
  • Prescribing of drugs [ Time Frame: Discharge from hospital ]

Enrollment: 400
Study Start Date: September 2007
Study Completion Date: July 2011
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Pharmacist service,
The pharmacist service consists of medication review, drug treatment discussion with the patient, and a medication report.
Other: Pharmacist service
Medication Review, medication report
No Intervention: Control
Usual care

Detailed Description:
A randomized controlled trial is performed in two internal medicine wards at Sahlgrenska University Hospital, Göteborg, Sweden.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients admitted to the wards during week days after decision of a ward physician or nurse if the medical condition allows inclusion

Exclusion Criteria:

  • Exclusion criteria are poor Swedish language and planned discharge before the intervention can be performed.
  • Patients transferred to wards not belonging to the department of medicine or other hospitals during the hospital stay are also excluded.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01016301


Locations
Sweden
Sahlgrenska University Hospital
Mölndal, Sweden, 431 80
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
Investigators
Principal Investigator: Susanna Wallerstedt, MD, Ass Prof Sahlgrenska University Hospital, Sweden